Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Component
2.3.2 Market Size By Type
2.3.3 Market Size By Application
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Country, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO's Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter's) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Component & Subsystem Suppliers
3.4.2. RFID in Pharmaceutical Solution Providers
3.4.3. Distributors & Channel Partners
3.4.4. End Users (Drug Manufacturers, Hospital & Clinical Pharmacies, Retail & E-Pharmacies, Distributors & Wholesalers)
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 RFID Adoption & Deployment Metrics
4.1.1 Pharmaceutical RFID Tag Adoption Rates
4.1.2 RFID-Enabled Drug Packaging Penetration
4.1.3 RFID Deployment Across Pharmaceutical Warehouses
4.1.4 RFID Adoption Across Hospitals & Pharmacies
4.2 Pharmaceutical Supply Chain Tracking Statistics
4.2.1 RFID-Tracked Pharmaceutical Shipment Volumes
4.2.2 Drug Inventory Tracking & Visibility Rates
4.2.3 Pharmaceutical Cold Chain Monitoring Adoption
4.2.4 Drug Traceability & Recall Response Efficiency
4.3 RFID Technology & Infrastructure Metrics
4.3.1 RFID Reader Installation & Deployment Trends
4.3.2 Passive vs. Active RFID Tag Utilization
4.3.3 RFID System Integration with Serialization Platforms
4.3.4 RFID Interoperability with ERP & Warehouse Management Systems
4.4 Operational Efficiency & Cost Metrics
4.4.1 Inventory Accuracy Improvement Rates
4.4.2 Pharmaceutical Product Loss & Shrinkage Reduction
4.4.3 Drug Receiving, Picking & Dispatch Processing Times
4.4.4 RFID Implementation & Operating Cost Benchmarks
4.5 Regulatory Compliance & Innovation Indicators
4.5.1 RFID Adoption for Drug Authentication
4.5.2 Pharmaceutical Traceability Compliance Metrics
4.5.3 RFID Integration with Electronic Product Codes
4.5.4 RFID Technology Investment & Product Launch Activity
5. North America RFID in Pharmaceuticals Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 RFID Tags
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 RFID Readers
5.4 RFID Middleware
5.5 Software & Services
6. North America RFID in Pharmaceuticals Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Chipped RFID
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Chipless RFID
7. North America RFID in Pharmaceuticals Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Drug Tracing & Authentication
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Drug Quality & Condition Monitoring
7.4 Inventory & Supply Chain Management
7.5 Anti-Counterfeiting
8. North America RFID in Pharmaceuticals Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Drug Manufacturers
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Hospital & Clinical Pharmacies
8.4 Retail & E-Pharmacies
8.5 Distributors & Wholesalers
9. North America RFID in Pharmaceuticals Market Segmental Analysis & Forecast By Country, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 US
9.2.1 Key Trends
9.2.2 North America RFID in Pharmaceuticals Market Size & Forecast, By Component, 2022–2035
9.2.3 North America RFID in Pharmaceuticals Market Size & Forecast, By Type, 2022–2035
9.2.4 North America RFID in Pharmaceuticals Market Size & Forecast, By Application, 2022–2035
9.2.5 North America RFID in Pharmaceuticals Market Size & Forecast, By End User, 2022–2035
9.3 Canada
9.3.1 Key Trends
9.3.2 North America RFID in Pharmaceuticals Market Size & Forecast, By Component, 2022–2035
9.3.3 North America RFID in Pharmaceuticals Market Size & Forecast, By Type, 2022–2035
9.3.4 North America RFID in Pharmaceuticals Market Size & Forecast, By Application, 2022–2035
9.3.5 North America RFID in Pharmaceuticals Market Size & Forecast, By End User, 2022–2035
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Avery Dennison Corporation
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Zebra Technologies Corporation
10.6.3 Impinj, Inc.
10.6.4 CCL Industries Inc. (Smartrac)
10.6.5 Fresenius Kabi AG
10.6.6 Checkpoint Systems, Inc.
10.6.7 NXP Semiconductors N.V.
10.6.8 SATO Holdings Corporation
10.6.9 Schreiner MediPharm
10.6.10 Tageos SAS
10.6.11 GAO RFID Inc.
10.6.12 Invengo Technology Corp.
10.6.13 Honeywell International Inc.
10.6.14 Siemens AG
10.6.15 Bluesight, Inc.
10.6.16 Paragon ID Plc
10.6.17 Turck Vilant Systems
10.6.18 p-Chip Corporation
10.6.19 Confidex Ltd.
10.6.20 Mojix, Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Key players in the North America RFID in Pharmaceuticals Market include Avery Dennison Corporation, Zebra Technologies Corporation, Impinj, Inc., CCL Industries Inc., and Fresenius Kabi AG, among others.
Key opportunities include automated bulk verification at distribution and returns points, sensor-enabled cold-chain monitoring, and expanding chipless tag adoption across the region.
The market is driven by DSCSA serialization enforcement, expanding biologics manufacturing, and growing hospital and retail pharmacy automation across the region.
The RFID Tags segment dominated the North America RFID in Pharmaceuticals Market, accounting for approximately 46.20% share in 2025.
The U.S. dominated the North America RFID in Pharmaceuticals Market in 2025 with an 88.90% share, driven by its large pharmaceutical manufacturing base and DSCSA enforcement pressure.
